Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/ADMA Biologics faces securities fraud probe after 29% stock drop over alleged channel stuffing.
ADMA
$8.62
-$0.06 -0.75%

ADMA Biologics faces securities fraud probe after 29% stock drop over alleged channel stuffing.

Market News
27 Mar 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

ADMA Biologics is under investigation by law firm Bleichmar Fonti & Auld for possible securities fraud following a 29% stock price drop. The decline came after Culper Research accused the company of channel stuffing—artificially inflating 2025 revenue growth by pushing excess inventory to distributors with rebates and extended payment terms. This alleged scheme masked a real 3% revenue decline as 20% growth was reported. Investors who suffered losses are encouraged to contact the law firm for potential legal action.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App